This paper studies the global stability of two discrete-time HIV infection models. The models integrate (i) latently infected cells, (ii) long-lived chronically infected cells and (iii) short-lived infected cells. The second model generalizes the first one by assuming that the incidence rate of infection as well as the production and removal rates of the HIV particles and cells are modeled by general nonlinear functions. We discretize the continuous-time models by using a nonstandard finite difference scheme. The positivity and boundedness of solutions are established. The basic reproduction number is derived. By using the Lyapunov method, we prove the global stability of the models. Numerical simulations are presented to illustrate our theoretical results. MSC: 34D20; 34D23; 37N25; 92B05
Introduction
Modeling and analysis of within-host human immunodeficiency virus (HIV) dynamics have received considerable attention from biologists and mathematicians during the last decades (see, e.g., ). The main target of the HIV is the CD4 + T cell. HIV causes the deadly disease acquired immunodeficiency syndrome (AIDS). Mathematical models of HIV dynamics are useful for describing the interaction between the host cells and HIV [2] . The basic HIV dynamics model which describes the interaction between the HIV (p), uninfected CD4 + T cells (s) and infected CD4 + T cells (z) has been proposed by Nowak and Bangham [1] . Callaway and Perelson [3] have extended the basic HIV dynamics model by taking into consideration three classes of infected cells: (i) latently infected cells (w) which cannot generate HIV particles, (ii) short-lived infected cells (z) which live for short time and generate large numbers of HIV particles, and (iii) long-lived chronically infected cells (u) which live for long time and generate small numbers of HIV particles:
u = (1 -)k 3 spau, ( 4 ) p = N z dz + N u aucp, ( 5 ) wherek =k 1 +k 2 +k 3 represents the incidence rate constant. β represents the rate at which new CD4 + T cells are created from sources. δ is the death rate constant of the uninfected CD4 + T cells. The parameters α, d, a and c denote the death rate constants of the latently infected cells, short-lived infected cells, long-lived chronically infected cells and free HIV particles, respectively. The parameters N z and N u represent the average number of HIV particles produced in the lifetime of the short-lived infected cells and long-lived chronically infected cells, respectively. The term mw is the activation rate of the latently infected cells, and represents the drug efficacy, where 0 ≤ ≤ 1. This model has been extended in [10] by considering time delay. Several authors have devoted their efforts in studying the global stability of mathematical models in virology (see, e.g., [7, [16] [17] [18] [19] [20] [21] [22] and [24] [25] [26] [27] [28] [29] [30] ) and epidemiology (see, e.g., [31, 32] ). Most of the HIV dynamics models presented in the literature are given by systems of nonlinear differential equations. Therefore, the exact analytical solutions of these continuous-time models are unknown. It is important to note that scientists often collect the data and analyze the results at discrete times. Further, the use of digital computers in performing numerical simulations of nonlinear systems necessitated the investigation of the discrete-time models. Consequently, a discretization can be used to obtain a discretetime model which is an approximation of the exact solution. However, how to select a proper discrete method so that the global properties of solutions of the corresponding continuous-time models can be efficiently preserved is still an open problem [33] . The mixed Euler method which is a mixture of both forward and backward Euler methods has been used for within-host virus dynamics governed by ordinary differential equations (ODEs) in [34, 35] , for delayed virus dynamics models governed by delay differential equations (DDEs) in [36] . The mixed Euler method has been utilized for virus dynamics models with diffusion governed by partial differential equations (PDEs) in [37] and delayed partial differential equations (DPDEs) in [38] . It has been proven that the mixed Euler method can preserve the positivity and boundedness of solutions, moreover, it can preserve the global stability of equilibria of the corresponding continuous-time system with no restriction on the space and time step sizes [38] .
Mickens [39] has introduced nonstandard finite difference (NSFD) scheme for solving differential equations. It has been proven that NSFD can preserve the main properties of several types of continuous-time models. The main advantage of NSFD approach is that the essential qualitative features of the mathematical model such as equilibria, positivity, boundedness and global behaviors of solutions are preserved independently of the chosen step-size [40] . On the other hand, even though there exist some general methods for construction of NSFD schemes for certain systems of ordinary differential equations (see, e.g., [41, 42] ), there is no universal NSFD scheme suitable for every mathematical model. Therefore every model requires the construction of an individual numerical scheme in order to obtain the correct qualitative results. NSFD has been widely employed in the study of different epidemic models (see, e.g., [33] and [43] [44] [45] [46] ). NSFD has been used for within-host virus dynamics models governed by • ODEs: Virus dynamics models governed by ODEs have been studied by considering Holling type-II infection function in [47] and CTL immune response in [40] and [48] . • DDEs: Delayed virus dynamics models given by DDEs has been studied by [49] . • PDEs: Virus dynamics models with diffusion given by PDEs have been studied by considering: general infection function [50] , both virus-to-cell and cell-to-cell transmissions in [51] and latently infected cells in [52] . Diffusive HBV infection model with HBV DNA-containing capsids has been studied in [53] . • DPDEs: Delayed virus dynamics models with diffusion have been studied by considering general nonlinear incidence rate in [54] . The HBV model presented in [53] has been extended by incoporating time delay in [55] and [56] . All the above-mentioned discrete-time virus dynamics models have considered one or two classes of infected cells. In this paper, our target is to study two discrete time HIV infection models with three categories of infected cells, latently infected cells, short-lived infected cells and long-lived chronically infected cells. The first model is obtained by discretizing system (1)-(5) using NSFD. The second model extends the first one by considering that the incidence rate of infection as well as the production and removal rates of the HIV particles and cells are modeled by general nonlinear functions. Positivity and boundedness properties of the solutions are proven. Further, global stability of the equilibria is established by constructing Lyapunov functions and by applying LaSalle's invariance principle.
Discrete-time model
Discretizing system (1)-(5) using the NSFD method [39] we obtain s n+1s n = βδs n+1ks n+1 p n ,
w n+1w n = k 1 s n+1 p n -(α + m)w n+1 ,
z n+1z n = k 2 s n+1 p n + mw n+1dz n+1 ,
where, k = k 1 + k 2 + k 3 , k i = (1 -)k i , i = 1, 2, 3 and n ∈ N = {0, 1, 2, . . .}. We consider the initial conditions:
Preliminaries
Let us consider the region
Proof From Eqs. (6)-(10) we obtain
Since all parameters in (6)-(10) are positive, by induction we get s n > 0, w n > 0, z n > 0, u n > 0 and p n > 0 for all n ∈ N. Define a sequence M n :
M n = s n + w n + z n + u n .
Then
According Lemma 2.2 in [34] we obtain
Hence
By induction we get
Consequently, lim n→∞ sup p n ≤ N 2 . Therefore, the solution (s n , w n , z n , u n , p n ) converges to Γ 1 as n → ∞. System (6)-(10) has two equilibria,
Clearly, Q * exists only when R 0 > 1, where R 0 is basic reproduction number and is given by
where
Global stability
We define the function
Proof Construct a discrete Lyapunov function:
where η i > 0, i = 1, 2, 3, 4 to be determined below.
Hence, L n > 0 for all s n > 0, w n > 0, z n > 0, u n > 0 and p n > 0. In addition, L n = 0 if and only if s n = s 0 , w n = 0, z n = 0, u n = 0 and p n = 0. Computing the difference L n = L n+1 -L n :
where η i , i = 1, 2, 3, 4 will be chosen below. Using inequality (18), we have
From Eqs. (6)-(10), we have
Let η i , i = 1, 2, 3, 4, be chosen so that
The solution of system (19) is given by
and will be used throughout the paper. Then
Hence, for R 0 ≤ 1, we have L n ≤ 0 for all n ≥ 0, hence L n is a non-increasing sequence. Then there exists a constant L such that lim n→∞ L n = L which implies that lim n→∞ L n = lim n→∞ (L n+1 -L n ) = 0. From equality (10) and lim n→∞ L n = 0 we have lim n→∞ s n = s 0 and lim n→∞ (R 0 -1)p n = 0. For the case R 0 < 1, we have lim n→∞ s n+1 = s 0 and lim n→∞ p n = 0. From Eqs. (7)- (10), we obtain lim n→∞ w n = 0, lim n→∞ z n = 0 and lim n→∞ u n = 0. For the case R 0 = 1, we have lim n→∞ s n+1 = s 0 . From Eqs. (7)- (10), we obtain lim n→∞ p n = 0, lim n→∞ u n = 0, lim n→∞ z n = 0 and lim n→∞ w n = 0. Hence, in the case R 0 ≤ 1, the HIV-free equilibrium Q 0 is globally asymptotically stable.
where η i , i = 1, 2, 3, 4 are given by Eq. (20) . Clearly, U n (s n , w n , z n , u n , p n ) > 0 for all s n , w n , z n , u n , p n > 0 and U n (s * , w * , z * , u * , p * ) = 0. Computing U n = U n+1 -U n :
Using inequality (18), we get
Since β = δs * + ks * p * ,
Using the conditions of Q * k 1 s * p * = (α + m)w * ,
Thus, U n is a non-increasing sequence and there exists a constant U such that lim n→∞ U n = U. Therefore, lim n→∞ U n = 0, which implies lim n→∞ s n = s * , lim n→∞ w n = w * , lim n→∞ z n = z * , lim n→∞ u n = u * and lim n→∞ p n = p * .
General model
In this section, we propose a general nonlinear HIV model:
where π , f and g i , i = 1, . . . , 4 are general functions and are assumed to satisfy the following conditions [24] :
ds ( ∂f (s,0) ∂p ) > 0 for all s > 0. (A3) (i) g j (ρ) > 0 for ρ > 0, g j (0) = 0, j = 1, . . . , 4, (ii) g j (ρ) > 0 for ρ > 0, j = 1, 2, 3 and g 4 (ρ) > 0 for ρ ≥ 0, (iii) there are υ j > 0, j = 1, . . . , 4 such that g j (ρ) ≥ υ j ρ for ρ ≥ 0. (A4) f (s,p) g 4 (p) is decreasing with respect to p for all p > 0. Using the NSFD method we get
Preliminaries
Let us consider the region Proof When n = 0 we prove that (s 1 , w 1 , z 1 , u 1 , p 1 ) exists and is positive. From Eq. (27) we have
Let ϕ 1 (s) be defined by
According to (A1)-(A2) ϕ 1 is a strictly increasing function of s. In addition
Hence, there exists a unique s 1 ∈ (0, ∞) such that ϕ 1 (s 1 ) = 0. From Eqs. (28) we have
Let ϕ 2 (w) be defined:
Based on (A1)-(A3) ϕ 2 is a strictly increasing function of w
Hence, there exists a unique w 1 ∈ (0, ∞) such that ϕ 2 (w 1 ) = 0. From Eqs. (29) we have
Let ϕ 3 (z) be defined by
Based on (A1)-(A3) ϕ 3 is a strictly increasing function of z
Hence, there exists a unique z 1 ∈ (0, ∞) such that ϕ 3 (z 1 ) = 0. Similarly, one can easily show from Eqs. (30)-(31) that u 1 ∈ (0, ∞) and p 1 ∈ (0, ∞).
Therefore, by using the induction, we obtain s n > 0, w n > 0, z n > 0, u n > 0 and p n > 0 for all n ≥ 0.
Define a sequence M n :
Consequently, lim n→∞ sup M n ≤N 1 , lim n→∞ sup s n ≤N 1 , lim n→∞ sup w n ≤N 1 , lim n→∞ sup z n ≤N 1 , lim n→∞ sup u n ≤N 1 . Moreover, p n+1p n = N z dg 2 (z n+1 ) + N u ag 3 (u n+1 )cg 4 (p n+1 ) ≤ N z dg 2 (N 1 ) + N u ag 3 (N 1 )cυ 3 p n+1 .
Hence p n+1 ≤ p n 1 + cυ 3 + (N z dg 2 (N 1 ) + N u ag 3 (N 1 )) 1 + cυ 3 .
Consequently, lim n→∞ sup p n ≤N 2 . Therefore, the solution (s n , w n , z n , u n , p n ) converges tō Γ 1 as n → ∞. 
N z dg 2 (z) + N u ag 3 (u)cg 4 (p) = 0.
From Eqs. (32)-(36) we have
Let us define We note from Assumption (A2) that ∂f (s 0 ,0) ∂s = 0. Then
From Eq. (38), we get
Therefore, from Assumption (A1), we have π (s 0 ) < 0. Therefore, if γ 
It means that a persistent-HIV equilibrium Q * (s * , w * , z * , u * , p * ) exists when γ g 4 (0) × ∂f (s 0 ,0) ∂p > 1. Hence, we can define the basic reproduction number of system (27)-(31):
∂p .
This shows that if R 0 > 1, then there exists a persistent-HIV equilibrium Q * (s * , w * , z * , u * , p * ). Proof Define
Global stability
Hence, L n > 0 for all s n , w n , z n , u n , p n > 0 and L n = 0 if and only if s n = s 0 , w n = 0, z n = 0, u n = 0 and p n = 0. Computing the difference L n = L n+1 -L n :
Using Lemma 2.1 [35] , we get
From Eqs. (27)-(31), we have
Using π(s 0 ) = 0, we obtain
From Assumption (A4) we have
Then we get = π(s n+1 )π s 0 1 -∂f (s 0 , 0)/∂p ∂f (s n+1 , 0)/∂p + η 4 c(R 0 -1)g 4 (p n ).
From Assumptions (A1) and (A2) we have
Hence, for R 0 ≤ 1, we have L n ≤ 0 for all n ≥ 0, hence L n is a non-increasing sequence. Then there exists a constant L such that lim n→∞ L n = L, and then lim n→∞ L n = 0 which implies that lim n→∞ s n = s 0 and lim n→∞ (R 0 -1)p n = 0. We discuss two cases:
• If R 0 < 1, then lim n→∞ p n = 0, then we get from Eqs. (28)-(30) lim n→∞ w n = 0, lim n→∞ z n = 0 and lim n→∞ u n = 0. • If R 0 = 1. By using lim n→∞ s n = s 0 and from Eq. (27) , we obtain f (s 0 , p n ) = 0. Because s 0 > 0, we have f (s 0 , p n ) > f (0, p n ) = 0 (use Assumption (A1)). Thus, lim n→∞ p n = 0. By the aforementioned discussion, we deduce that the largest compact invariant set in {(s n , w n , z n , u n , p n )|( L n ) = 0} is the just the singleton Q 0 .
Therefore, Q 0 is globally asymptotically stable by the LaSalle invariance principle [57, 58] .
where λ > 0 and θ > 0. Therefore, system (27)-(31) becomes s n+1s n = βδs n+1 -ks n+1 p n 1 + λs n+1 + θ p n ,
For this system, the basic reproduction number is given by
We verify the assumptions (A1)-(A4). Clearly, π(0) = β > 0, π(s 0 ) = 0 and π (s) = -δ < 0. It follows that, π(s) > 0 for all s ∈ [0, s 0 ). Moreover, (A1)(iii) is satisfied with b = β andb = δ. Thus, (A1) is satisfied. We also have Therefore, Assumption (A2) is satisfied. Moreover, we have g j (ρ) = ρ > 0 for all ρ > 0 and g j (0) = 0, j = 1, . . . , 4. We also have, g j (ρ) = 1 > 0, j = 1, 2, 3 for all ρ > 0 and g 4 (ρ) = 1 > 0 for ρ ≥ 0.
Then Assumption (A3) is satisfied, where υ j = 1, j = 1, 2, 3. Finally, we have ∂ ∂p f (s, p) g 4 (p) = -θ s (1 + λs + θ p) 2 < 0, for all s > 0, and p > 0. Therefore, Assumption (A4) holds true and hence Theorems 3 and 4 are applicable.
The numerical simulations for system (41)-(45) will be conducted using the following data: β = 10, δ = 0.01, α = 0.1, m = 0.2, d = 0.2, a = 0.1, c = 6, λ = 1, θ = 1 andk i = 0.02 (i = 1, 2, 3). The other parameters will be chosen below.
Let us consider the initial values Figure 1 shows that, the concentration of uninfected cells increases and tends to the value s 0 = 1000. In addition, the concentrations of latent infected cells, long-lived infected cells, short-lived infected cells and free HIV particles decrease and tend to zero for the initial values IV1-IV3. This shows that Q 0 is globally asymptotically stable and Theorem 3 is valid. (ii) N z = 200, N u = 100. With these values we obtain R 0 = 1.4430 > 1. Figure 1 shows that for the initial values IV1-IV3, the solutions of the system tend to the equilibrium Q * = (352.8108, 7.1910, 17.9775, 21.5730, 155.8047). Therefore, Q * exists and it is globally asymptotically stable. This validates the result of Theorem 4.
Case(2) Effect of the drug efficacy on the HIV dynamics:
For this case, we take IV2 and choose the values N z = 200, N u = 100 and is varied. Figure 2 shows the effect of drug efficacy on the stability of the system. We observe Figure 2 The simulation of trajectories of system (41)- (45) for Case (2) that, as is increased, the infection rate is decreased, and then, the concentration of the uninfected cells are increased, while the concentrations of the latent infected cells, longlived infected cells, short-lived infected cells and free HIV particles are decreased.
